Skip to main content

BALCHEM CORP

corporate_fare Company Profile

BALCHEM CORP

BCPC·NASDAQ·Basic Materials·CIK 0000009326

Balchem Corporation, incorporated in Maryland in 1967, develops, manufactures, distributes, and markets specialty performance ingredients and products. These products serve the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. The company operates through three reportable segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Sales and production from activities outside these segments and other minor business activities are categorized as "Other and Unallocated." Balchem sells its products through its own sales force, independent distributors, and sales agents. The Human Nutrition and Health (HNH) segment offers human-grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. Choline is recognized for its role in the development and structural integrity of brain cell membranes in infants, processing dietary fat, reproductive development, and neural functions like memory and muscle function. The company's mineral amino acid chelates, specialized mineral salts, and mineral complexes are used as raw materials in premier human nutrition products. Proprietary technologies are used to create organic molecules in a form the body can readily assimilate. Sales growth in human nutrition applications depends on differentiating products from lower-cost competitors through scientific data, intellectual property, and customer brand appreciation.

BALCHEM CORP (NASDAQ:BCPC) is a publicly traded company in the Basic Materials sector. Wiseek monitors BCPC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Balchem Reports Record Q1 2026 Financial Results with Strong Sales and Earnings Growth Across All Segments
  • Balchem's Q1 Sales Jump 8%, Beats Estimates with Strong EPS Growth Across All Segments
  • Balchem Reports Record 2025 Financials with Strong Growth and Launches New Share Repurchase Program
  • Balchem Reports Record Q4 and Full-Year 2025 Results with Strong Growth Across All Segments

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.04B
Net Income
$154.84M
Diluted EPS
$4.75
Op. Cash Flow
$216.56M
Gross Profit
$370.63M
Operating Income
$209.33M
Cash & Equivalents
$74.57M
Debt / Equity
0.00×
Net Margin
14.9%
Shares Outstanding
32.06M sh
Source: 10-K · filed 2026-02-20 · accession 0000009326-26-000007
Browse all tickers starting with B →
$161.65
52-week range · as of 2026-04-30 $139.17 – $183.9
Market cap
$5.19B
Volume
184.8K (0.9× avg)
3-mo avg 195.6K
Live data · 2026-06-11 07:22 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed BCPC - Latest Insights

BCPC
Apr 30, 2026, 7:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $173.33
Real-time Price: $161.65 info
Change: -$11.68 (-7%) info
Market Cap: $5.194B info
BCPC
Apr 30, 2026, 7:25 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $173.33
Real-time Price: $161.65 info
Change: -$11.68 (-7%) info
Market Cap: $5.194B info
BCPC
Feb 20, 2026, 4:26 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $172.00
Real-time Price: $161.65 info
Change: -$10.35 (-6%) info
Market Cap: $5.194B info
BCPC
Feb 20, 2026, 7:38 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $175.00
Real-time Price: $161.65 info
Change: -$13.35 (-8%) info
Market Cap: $5.194B info